| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A road map for navigating CAR T hematotoxicity
|
Qualls, David
|
|
|
142 |
10 |
p. 859-861
|
artikel
|
| 2 |
Back Matter
|
|
|
|
142 |
10 |
p. II
|
artikel
|
| 3 |
Burkitt lymphoma genomic discovery studies, drivers, and validation
|
Dave, Sandeep S.
|
|
|
142 |
10 |
p. 936-938
|
artikel
|
| 4 |
Concerning data inconsistencies in Burkitt lymphoma genome study
|
Rushton, Christopher K.
|
|
|
142 |
10 |
p. 933-936
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
142 |
10 |
p. vi
|
artikel
|
| 6 |
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma
|
Armand, Philippe
|
|
|
142 |
10 |
p. 878-886
|
artikel
|
| 7 |
Hydrophilic polymer embolus in the bone marrow
|
Rangan, Aruna
|
|
|
142 |
10 |
p. 939
|
artikel
|
| 8 |
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
|
Rejeski, Kai
|
|
|
142 |
10 |
p. 865-877
|
artikel
|
| 9 |
Loss of miR-144/451 alleviates β-thalassemia by stimulating ULK1-mediated autophagy of free α-globin
|
Keith, Julia
|
|
|
142 |
10 |
p. 918-932
|
artikel
|
| 10 |
Masthead Subscription
|
|
|
|
142 |
10 |
p. i
|
artikel
|
| 11 |
Panea RI, Love CL, Shingleton JR, et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood. 2019;134(19):1598-1607.
|
|
|
|
142 |
10 |
p. 940
|
artikel
|
| 12 |
Pembrolizumab: a key for some, but not all, HL
|
Cheah, Chan Y.
|
|
|
142 |
10 |
p. 861-862
|
artikel
|
| 13 |
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma
|
Sloan, Shelby L.
|
|
|
142 |
10 |
p. 887-902
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
142 |
10 |
p. iii-iv
|
artikel
|
| 15 |
The incredible ULK improves β-thalassemia
|
Babbs, Christian
|
|
|
142 |
10 |
p. 862-863
|
artikel
|
| 16 |
The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment
|
Fei, Ming-Yue
|
|
|
142 |
10 |
p. 903-917
|
artikel
|
Tijdschrift beschrijving